FDA approved Q BioMed Inc.’s contract manufacturer IsoTherapeutics Group LLC Nov. 20, which it cleared to manufacture the company’s FDA-approved non-opioid cancer bone pain drug Strontium-89 Chloride USP.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
